Transcend Capital Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Buy |
876
+54
| +7% | +$21K | 0.03% | 421 |
|
|
2025
Q1 | $358K | Buy |
822
+175
| +27% | +$76.1K | 0.03% | 437 |
|
|
2024
Q4 | $239K | Sell |
647
-121
| -16% | -$44.6K | 0.02% | 490 |
|
|
2024
Q3 | $400K | Buy |
768
+26
| +4% | +$13.5K | 0.03% | 428 |
|
|
2024
Q2 | $402K | Sell |
742
-43
| -5% | -$23.3K | 0.03% | 402 |
|
|
2024
Q1 | $407K | Sell |
785
-24
| -3% | -$12.4K | 0.03% | 356 |
|
|
2023
Q4 | $381K | Buy |
809
+34
| +4% | +$16K | 0.03% | 347 |
|
|
2023
Q3 | $337K | Buy |
775
+27
| +4% | +$11.8K | 0.03% | 354 |
|
|
2023
Q2 | $333K | Sell |
748
-167
| -18% | -$74.2K | 0.03% | 353 |
|
|
2023
Q1 | $421K | Sell |
915
-40
| -4% | -$18.4K | 0.04% | 311 |
|
|
2022
Q4 | $490K | Sell |
955
-266
| -22% | -$136K | 0.05% | 286 |
|
|
2022
Q3 | $555K | Sell |
1,221
-111
| -8% | -$50.5K | 0.06% | 264 |
|
|
2022
Q2 | $643K | Sell |
1,332
-3
| -0.2% | -$1.45K | 0.07% | 262 |
|
|
2022
Q1 | $656K | Sell |
1,335
-95
| -7% | -$46.7K | 0.06% | 279 |
|
|
2021
Q4 | $663K | Sell |
1,430
-46
| -3% | -$21.3K | 0.06% | 267 |
|
|
2021
Q3 | $644K | Buy |
1,476
+136
| +10% | +$59.3K | 0.06% | 257 |
|
|
2021
Q2 | $511K | Buy |
1,340
+28
| +2% | +$10.7K | 0.07% | 205 |
|
|
2021
Q1 | $472K | Sell |
1,312
-49
| -4% | -$17.6K | 0.06% | 253 |
|
|
2020
Q4 | $437K | Buy |
+1,361
| New | +$437K | 0.06% | 249 |
|